Notice for dupilumab (Sanofi-Aventis Australia Pty Ltd)
Active ingredients
dupilumab
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
pre-filled syringe or pre-filled pen administered by subcutaneous injection
Indication
For the treatment of bullous pemphigoid
Therapeutic area
Dermatology